Accreditation Information

iScience 2019 Credit Information, Terms of Service, and License Agreement

The Terms of Service and License Agreement set forth below constitute a legal agreement (collectively, the “Agreement”) between the American College of Cardiology Foundation (“ACCF”) and You and your agents (“You” or “Your”) for the use of the iScience 2019 (the “Product”).   

By clicking on the Agree button below, and by using the Product, You accept and agree to be bound by all of the terms and conditions set forth in this Agreement. If You do not wish to accept the terms and conditions of this Agreement, You may not proceed to use the Product.

ACCF may change the terms of this Agreement from time to time without further notice directly to You. When the terms are changed, ACCF will post a general conspicuous notice. If You do not agree with the revised terms, please discontinue use of the Product immediately. Your continued use of the Product following such notice constitutes your acceptance of and agreement to be bound by any revised terms of the Agreement. This Agreement expressly incorporates by reference and includes any and all rules or disclaimers that may be posted and updated within the Product or communicated to You from time to time.

Information Regarding this Product

iScience, the ACC.19 Meeting On Demand™ Program is a digital library of more than 360 hours of educational content presented at the ACC.19 meeting.

Features of iScience include:

  • Presenters’ slides with synchronized audio
  • Searchable slide content
  • Earn up to 100 AMA PRA Category 1 Credits™, CNE contact hours, CPE credits, and/or ABIM Medical Knowledge MOC points
  • C and MAC Compatible
  • Online access and offline access with hard drive
  • Mobile version for most tablets and smartphones
  • MP3 and PDF downloads

iScience includes key educational sessions including Late-Breaking Clinical Trials and highlights from all 10 learning pathways:

  • Acute and Stable Ischemic Heart Disease
  • Arrhythmias and Clinical Electrophysiology
  • Congenital Heart Disease
  • Heart Failure and Cardiomyopathies
  • Interventional Cardiology 
  • Non-Invasive Imaging
  • Prevention
  • Pulmonary Hypertension and Venous Thromboembolic Disease
  • Valvular Heart Disease
  • Vascular Medicine

Grant Acknowledgments:  No educational grants were provided for this activity.

Accreditation Information

Target Audience

iScience is intended for all professionals involved in delivering cardiovascular care, with particular emphasis on physicians, scientists, nurse practitioners, clinical nurse specialists, physician assistants, nurses, pharmacists, and practice administrators. Medical students and trainees, technicians, dietitians and other health care professionals will also benefit.

Accreditation for Physicians 

The American College of Cardiology Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The ACCF designates this enduring material for a maximum of 100 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 100 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Accreditation for Nurses

The American College of Cardiology Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (Provider No. P0019). 

The ACCF designates this activity for 100 CNE contact hours. Nurses should claim only the credit commensurate with the extent of their participation in this activity.

Accreditation for Pharmacists

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and American College of Cardiology Foundation. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Pharmcy Education

Postgraduate Institute for Medicine designates this continuing education activity for 100.0 contact hour(s) (10.0 CEUs) of the Accreditation Council for Phamacy Education. 

While offering the credits noted above, this program is not intended to provide extensive training or certification in the field.

Univerisal Activity Numbers: See evaluation survey for specific details.

*Please Note: If you already claimed credit for attending the ACC.19 meeting in New Orleans, you may not claim credit for the same session(s) in iScience. Physicians are allowed to claim CME, and/or MOC credit, Nurses can claim CNE contact hours, and Pharmacists can claim CPE credit.

Method of Participation and Claiming Credit 

This product offers up to 100 AMA PRA Category 1 Credits™, CNE contact hours, CPE credits, and/or ABIM Medical Knowledge MOC points based on the number of hours you spend watching presentations and taking the post-test questions.  You may re-enter the product as many times as you wish, but you can claim credit only once and must claim credit by March 16, 2020.

To receive credit for this product, you must:

  1. Purchase the product.
  2. Read the Credit Information when you first enter the player or by clicking the Credit Information link in the top right corner.
  3. View the session(s) of your choosing.
  4. Click the Credit/Test link in the top right corner after you have completed viewing all sessions for which you intend to claim credit.
  5. Complete the posttest.  You must score 70% to earn credit, but you can re-take test questions that you missed as many times as necessary.
  6. Enter the number of credits you wish to claim.  Credits claimed should reflect the total number of hours that you spent reviewing the Credit Information, watching sessions and taking the posttest.  
  7. If you are an ABIM Diplomate, you will then be asked to enter your ABIM ID and Date of Birth to claim MOC points. If you do not wish to claim MOC points, you can choose to not claim.
  8. Generate and print your certificate. If you are an ABIM Diplomate and claimed MOC points, your completion information will be transmitted to the ACCME/ABIM on your behalf.

*If you already claimed credit for attending the live ACC.19 meeting, you may not claim credit for the same sessions on iScience.

Important Dates:

Date of Release:  March 17, 2019

Term of Approval / Date of Expiration:  March 16, 2020

Please note that credit will only be available through the term of approval noted above, although you may continue to access iScience 2019 online through March 16, 2021.

Media or Combination of Media Used: 

iScience is available in the following formats:

  • Online access with downloadable MP3 files and PDF files
  • External hard drive
  • Mobile version for most tablets and smartphones

Hardware/Software Requirements

Please visit iScience.acc.org, and click System Requirements for the most up-to-date system requirements.

ACCF Learner Bill of Rights

The ACCF recognizes that You are a life- long learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge or skill; and to attain or enhance a desired competency. As a participant in an ACCF activity, You have the right to expect that your continuing medical education experience with ACCF includes the following:

Content that:

  • Promotes improvements or quality in healthcare.
  • Is current, valid, reliable, accurate and evidence-based. 
  • Addresses the stated objectives or purpose.
  • Is driven and based on independent survey and analysis of learner needs, not commercial interests.
  • Has been reviewed for bias and scientific rigor.
  • Offers balanced presentations that are free of commercial bias.
  • Is vetted through a process that resolves any conflicts of interest of planners and faculty.
  • Is evaluated for its effectiveness in meeting the identified educational need.

A learning environment that:

  • Is based on adult learning principles that support the use of various modalities.
  • Supports learner’s abilities to meet their individual needs.
  • Respects and attends to any special needs of the learners. 
  • Respects the diversity of groups of learners.
  • Is free of promotional, commercial and/or sales activities.

Disclosure of:

  • Relevant financial relationships that planners, teachers and authors have with commercial interests related to the content of the activity.
  • Commercial support (funding or in-kind resources) of this activity.

Program Goals and Learning Objectives by Learning Pathway

Program Goals

ACC is dedicated to providing needs-based education that is independent of commercial interests and fosters change in learners™ knowledge, competence and performance to ultimately improve patient outcomes. The overall goals for iScience are:

  • To facilitate translation of cardiovascular science to all members of the care team leading to high-quality, patient-centered care
  • To allow for examination and discussion of important contributions and controversies in cardiovascular care
  • To promote cardiovascular science and education to a global audience

Acute and Stable Ischemic Heart Disease

As a result of participating in the Acute and Stable Ischemic Heart Disease Pathway sessions, learners will have an improved or reinforced ability to…

  1. Compare and contrast different STEMI and NSTEMI systems of care and logistical processes for managing complex patients with ACS
  2. Formulate a differential diagnosis and management strategy for athletes presenting with ischemic heart disease
  3. Scrutinize the methodology of recent acute and stable ischemic heart disease clinical trials to determine the implications and generalizability of findings
  4. Evaluate the evidence and different perspectives underlying current controversies in acute and stable ischemic heart disease diagnosis and management and ACS Guidelines, including international and other societal guidelines
  5. Describe the management of complications seen in ischemic heart diseases
  6. Discuss barriers to implementation of cardiac rehab and novel approaches
  7. Assess and appropriately manage patients with cardiogenic shock or in need of critical care
  8. Detect and manage patients with angina refractory that are resistant to conventional treatment options
  9. Identify the diagnosis and management of atypical ischemic heart disease presentations, including microvascular dysfunction, spontaneous coronary artery dissection, and ischemia without obstructive coronary artery disease
  10. Recognize cutting-edge approaches towards genetic testing for coronary artery disease

Arrhythmias and Clinical EP

As a result of participating in the Arrhythmias and Clinical EP Pathway sessions, learners will have an improved or reinforced ability to…

  1. Apply recent evidence and current guideline recommendations to the management of arrhythmias
  2. Integrate emerging evidence and options for prevention, detection, risk assessment, rhythm and rate management, and stroke prevention into the care of patients with atrial fibrillation
  3. Compare and contrast pharmacologic management and treatment of arrhythmias, including outcomes and risk of adverse events due to medications used to treat arrhythmias
  4. Identify patients and patient populations who can benefit from currently available device-based therapies
  5. Recognize and interpret salient ECG patterns and integrate into clinical decision-making
  6. Evaluate symptoms (eg. syncope) that arise due to arrhythmias in special populations, including in athletes, inherited arrhythmia conditions, pregnancy, and cardiomyopathy/heart failure
  7. Evaluate current findings from clinical trials and future implications in research
  8. Debate topical health trends and advancing technology utilized by both clinicians and patients, and implication on diagnosis and management of arrhythmias

Congenital Heart Disease

As a result of participating in the Congenital Heart Disease (CHD) Pathway sessions, learners will have an improved or reinforced ability to…

  1. Identify strategies to effectively evaluate and manage acquired pediatric heart disease
  2. Discuss innovative therapies and complex clinical scenarios in fetal cardiology
  3. Describe the role of novel transcatheter therapies and surgical techniques in the management of CHD
  4. Critically evaluate emerging imaging applications in CHD
  5. Incorporate recent advances and research into cardiology practice for CHD
  6. Explore challenging issues in heart failure management and electrophysiology in children and adults
  7. Review the contemporary management of pregnancy and other women’s health issues in patients with CHD

Heart Failure and Cardiomyopathies

As a result of participating in the Heart Failure and Cardiomyopathies Pathway sessions, learners will have an improved or reinforced ability to…

  1. Integrate contemporary concepts in cardiovascular pathophysiology with evidence-based strategies in the diagnosis, evaluation, and management across the entire spectrum of patients with heart failure and cardiomyopathy
  2. Offer practical guidance on diet, exercise, support, and heart failure management that is appropriately tailored to diverse patient populations across various stages and types of heart failure
  3. Recognize the interaction between various comorbidities and heart failure, and best practices in the multidisciplinary approach
  4. Evaluate the role and indications for ICDs, CRTs, hemodynamic sensors, and mechanical support for heart failure management
  5. Expand knowledge in the evidence-based care of patients with infiltrative and inherited cardiomyopathy, and less common inherited and acquired cardiomyopathies
  6. Analyze the evidence on current and newer pharmacotherapies, devices, and therapies for best practices heart failure management
  7. Discuss future approaches to heart failure and cardiomyopathy diagnosis and management
  8. Develop insight to address the needs of specific patient populations with heart failure and cardiomyopathy, and at different stages of life

Interventional Cardiology

As a result of participating in the Interventional Cardiology Pathway sessions, learners will have an improved or reinforced ability to…

  1. Determine an appropriate antithrombotic regimen for diverse patients with acute coronary syndrome or undergoing a revascularization procedure, and address issues with antiplatelet regimens in patients at high risk for bleeding
  2. Interpret and integrate findings from adjunctive coronary and endovascular assessment into clinical decision-making
  3. Decide whether and how to revascularize patients who are high-risk or have complex coronary artery disease
  4. Evaluate the evidence from clinical trials describing outcomes, recent advances, and expanded applications of angiography and interventional cardiology
  5. Describe key tactics for preventing and managing interventional complications
  6. Appropriately incorporate new and state-of-the-art structural heart and endovascular technologies and techniques into patient care
  7. Work effectively as part of a comprehensive care team to manage patients before, during, and after interventional procedures
  8. Apply findings from diagnostic imaging to plan treatment, guide intervention, and gauge procedural outcomes

Noninvasive Imaging

As a result of participating in the Noninvasive Imaging Pathway sessions, learners will have an improved or reinforced ability to…

  1. Apply current imaging guidelines for the assessment of valvular, myocardial, coronary, pericardial, and complex congenital and structural heart diseases
  2. Identify both current and emerging roles of stress echocardiography for evaluating heart diseases
  3. Evaluate recent innovations in advanced imaging techniques and their potential applications
  4. Utilize findings from non-invasive imaging to clarify the etiology and guide the management of patients with heart failure or cardiomyopathy and systemic diseases involving the heart (e.g., cardiac amyloidosis, sarcoidosis)
  5. Recognize the prognostic implications of cardiac CT and cardiac MRI findings and their appropriate impact on patient management

Prevention

As a result of participating in the Prevention Pathway sessions, learners will have an improved or reinforced ability to…

  1. Apply current evidence base to determine thresholds for hypertension treatment, establish therapeutic goals, and implement team-based processes to achieve blood pressure control in simple and complex cases
  2. Recognize the implications of diabetes on cardiovascular disease and tailor management strategies based on available evidence
  3. Evaluate the underlying evidence on dyslipidemia and ASCVD, including targeting novel pathways and the controversies in dyslipidemia management.
  4. Integrate best practices with regards to lifestyle and dietary recommendations to prevent or manage ASCVD and related diseases, such as diabetes
  5. Consider unique factors in prevention and management of ASCVD for vulnerable populations and the disparities in current research and guidelines
  6. Apply current cholesterol and other ASCVD prevention guidelines in practice

Pulmonary Hypertension and Venous Thromboembolic Disease

As a result of participating in the Pulmonary Hypertension and Venous Thromboembolic Disease Pathway sessions, learners will have an improved or reinforced ability to…

  1. Evaluate the diagnostic and therapeutic options for patients with pulmonary hypertension and the multiple potential etiologies of pulmonary hypertension
  2. Identify innovative translational discoveries and the potential for personalized medicine in PAH
  3. Apply current practice and innovative research to the cardiology practice for patient population with VTE
  4. Utilize shared decision making and adjunctive resources in caring for patients with pulmonary hypertension

Valvular Heart Disease

As a result of participating in Valvular Heart Disease (VHD) Pathway sessions, learners will have an improved or reinforced ability to…

  1. Apply recent updates to guidelines and recommend best practices for valvular care to clinical practice
  2. Recognize how the mechanism, natural history, diagnosis and treatment options of patients with valve disease continue to evolve and affect patient care algorithms
  3. Assess the role of imaging and physiologic testing in characterizing valvular disease and guiding management
  4. Incorporate the heart team approach to treatment of patients with VHD
  5. Incorporate the evidence on contemporary diagnostic and treatment options into clinical decision-making for patients with VHD
  6. Compare strategies in assessment, diagnosis and treatment of special populations with valvular heart disease

Vascular Medicine

As a result of participating in Vascular Medicine Pathway sessions, learners will have an improved or reinforced ability to…

  1. Evaluate the evidence associated with current management of vascular diseases 
  2. Incorporate recent clinical trial findings and evidence-based guideline recommendations into the treatment of patients with vascular disease, including special populations 
  3. Recognize effective treatment of common vascular and thrombotic complications of cancer and cancer-directed therapy

TERMS OF SERVICE AND LICENSE AGREEMENT

Term of Access and Termination

You acknowledge and agree that the Product is being provided to you online for a limited period of time, and that You will have access to the Product online through March 16, 2021. Your access to the Product will terminate upon the expiration of this specified period of time.  ACCF may terminate your access and/or the Product at any time for reasonable cause, upon notice to You. You agree that any such termination of your access to the Product shall not result in any liability or other obligation of ACCF to You, or any third party in connection with such termination.  

Intellectual Property Rights

This Product, including the information, text, graphics, images, audio and video files, trademarks and other materials that may be contained therein (collectively “Content”), and all right, title and interest therein, including copyright and all rights subsumed thereunder, is owned by ACCF, and to the extent any Content is not owned by ACCF, ACCF has obtained sufficient rights and permissions to include such Content in the Product.  The Content is protected by patents, copyrights, trademarks, and other proprietary rights. Except as otherwise specifically provided in this Agreement, your use of the Product shall be governed and constrained by applicable patent, copyright, trademark and other intellectual property laws.  ACCF grants You a limited, nonexclusive, nontransferable, non-sublicenseable, revocable license to utilize and access the Product for Your noncommercial, personal use according to the terms and conditions in this Agreement. You may not modify, publish, transmit, participate in the transfer or sale of, reproduce, create derivative works from, distribute, perform, display, incorporate into another website or any other medium, or in any other way exploit the Product and/or any of the Content, in whole or in part. Except as expressly granted by this Agreement, You acquire no right, title or interest in or to the Product or the Content or other data or materials incorporated in the Product. ACCF, American College of Cardiology (“ACC”), and any affiliates or licensors thereof shall retain all right, title and interest in the Product and Content.

Disclaimers

ACCF is not responsible for statements made by any contributor to the Product or for any errors or omissions or for the results obtained from use of the information contained in this Product. Statements or opinions expressed in this Product reflect the views of the contributors and do not reflect the official policy of ACCF or ACC. The Product and Content are provided on an “as is” and “as available” basis.  ACCF and ACC expressly disclaim all warranties of any kind with respect to the Product or Content, whether express or implied, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement.  ACCF makes no warranty that the Product and/or any Content therein will meet Your requirements, or will be accurate, complete or error-free, and further does not warrant that the results that may be obtained by Your use of the Product or any Content therein will be accurate or reliable.  

The Content on the Product is presented as an educational service intended for licensed healthcare professionals. While the Content in the Product is about specific medical and healthcare issues, the Content is not a substitute for or replacement of personalized medical advice and is not intended to be used as the sole basis for making individualized medical or health-related decisions.

You are advised to independently ensure that any recommended drug dosages in the Product concur with the information provided in the drug product information material. Application of the information in Product remains the sole professional responsibility of the practitioner and ACCF hereby expressly disclaims responsibility for any liability arising from or in connection with the application of the information in the Product by You.

The views and opinions expressed in the Product are those of the contributing authors and editors and do not necessarily represent the views of the ACCF. The material is not intended to present the only, or necessarily best, methods or procedures for the medical situations addressed, but rather is intended to represent an approach, view, statement or opinion.

Any reference to a specific therapy or commercial product in this Product does not constitute a guarantee, warranty, or endorsement by ACCF or ACC of the quality or value of such therapy or product, or a guarantee, warranty or endorsement by ACCF or ACC of any claims made by the manufacturer of such therapy or commercial product.  

Unapproved Use Disclosure

This Product may include discussion about pharmaceutical agents and/or medical devices/products that are outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these pharmaceutical agents and/or medical devices/products. If You have questions, contact the medical affairs department of the manufacturer for the most recent information.  Nothing herein is intended to be a promotion, endorsement, guarantee or warranty by ACCF of any such pharmaceutical agents and/or medical devices/products.

Disclosure/Conflict Of Interest

As a provider accredited by the ACCME and the ANCC, ACCF must ensure balance, independence, objectivity and scientific rigor in all of its directly provided or jointly provided/co-provided educational activities. Planners, presenters, and other contributors in a position to control the Content included in the Product are required to disclose to ACCF all relevant financial or other material relationships or interests he/she and/or his/her spouse or domestic partner may have, occurring within the past twelve (12) months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, ACCF requires the inclusion of a disclosure statement that the product is not labeled for the use under discussion or that the product is still investigational.

ACCF is committed to providing its learners with high-quality activities and materials that promote improvements and quality in health care, rather than a specific proprietary business or commercial interest. The intent of ACCF’s required disclosure is not to prevent participation in certified educational activities by persons with a financial or other material relationship with entities producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, but rather to provide learners with information on which they can make their own determination whether financial interests or material relationships may influence the certified activity.

ACCF assesses potential conflicts of interest disclosed by its faculty, contributors, planners, managers, staff and other individuals who are in a position to control the content of certified activities. All relevant potential conflicts of interest that are identified are thoroughly vetted through a process conducted by activity course directors, ACCF education staff, and members of the Accreditation Compliance Workgroup and that includes appropriate peer review for fair balance, scientific objectivity and validity, and patient care and safety recommendations.

ACC staff involved with this activity have nothing to disclose. 

Click here to see a list of disclosures for everyone involved in planning and presenting at ACC.19.

Intent of Question and Answer Section

The question and answer section of the Product was designed to stimulate thinking and motivate You to further research. Answers and commentary are based on the best judgment of the authors and contributors at the time the question was written. New knowledge, insights and perspectives may cause You to disagree with an author’s answer. ACCF encourages thoughtful discussion and consideration of each question’s answer and commentary. While most of the questions within the Product link back to related text, not all of them do. The ACCF Editorial Team’s™ philosophy is that questions are an opportunity to make an additional teaching point outside of the text or to incite the user to learn something above and beyond the text.

Release of Liability

You hereby agree to assume all risks associated with use of the Product including, but not limited to any harm, injury or damages resulting directly or indirectly from the use of the Product, all such risks being known and understood by You. In consideration of your use of the Product, You, for yourself, your successors, assigns and anyone entitled to act on your behalf, waive and forever release and discharge ACCF, its officers, trustees, employees, representatives and successors from any and all claims and liabilities of any kind arising out of or in connection with Your use or misuse of the Product.

Indemnification

You hereby agree to indemnify, save and hold ACCF, its directors, officers, shareholders, parents, subsidiaries, affiliates, agents and licensors harmless from and against any and all claims, liability, losses, damages and costs, including, without limitation, reasonable attorneys’ fees and costs, arising out of or in connection with Your use or misuse of the Product or Content, or any violation of this Agreement.  ACCF assumes the right, at Your expense, to assume the exclusive defense and control of any matter for which You are required to indemnify ACCF, and You agree to cooperate with ACCF’s defense of these claims.  ACCF will use reasonable efforts to notify You of any such claim, action, or proceeding upon becoming aware of it. 

Miscellaneous

This Agreement is personal to You, and You may not assign your rights or obligations to any other individual or entity.  Neither failure nor delay on the part of any party to exercise any right, remedy, power or privilege hereunder nor course of dealing between the parties shall operate as a waiver thereof, or of the exercise of any other right, remedy, power or privilege. No term of this Agreement shall be deemed waived, and no breach consented to, unless such waiver or consent shall be in writing and signed by the party claimed to have waived or consented. No waiver of any rights or consent to any breaches shall constitute a waiver of any other rights or consent to any other breach.  If any provision in this Agreement is held invalid or unenforceable under applicable law, the remaining provisions shall continue in full force and effect.  This Agreement will be governed by and construed exclusively in accordance with the laws of the District of Columbia, USA, without regard to its conflicts of law principles and, to the extent applicable, the federal laws of the United States.

Provider Contact Information:

For Customer Support:

iscience@acc.org or (818) 844-3299; Toll Free (800) 501-2303 (U.S.A. only)

For questions about ACC activities:

ACC Member Care at (202) 375-6000, ext. 5603 or (800) 253-4636, ext. 5603.

ACC Policy on Privacy and Confidentiality:

http://www.acc.org/footer-pages/privacy-policy

Copyright ©2019 American College of Cardiology Foundation 

All Rights Reserved.

Please obey all copyright laws. 

Made in the USA.

No part of this Product may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage or retrieval system without permission in writing from the American College of Cardiology Foundation.

Features of
iScience 2019

desktop monitor icon

Access Content From Any Device for 1 Year
downloadable content icon

Downloadable PDFs and MP3 files
Close Menu